TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Genon Biotechnologies Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
66
|
66
|
78 |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
42
|
41
|
44 |
| Total assets |
420
|
423
|
425 |
| Current assets |
76
|
60
|
74 |
| Current liabilities |
0
|
2
|
3 |
| Equity capital |
419
|
420
|
422 |
| - share capital |
8
|
8
|
8 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
99.8%
|
99.3%
|
99.3% |
| Turnover per employee |
33
|
33
|
39 |
| Profit as a percentage of turnover |
63.6%
|
62.1%
|
56.4% |
| Return on assets (ROA) |
9.7%
|
10.4% | |
| Current ratio |
3000%
|
2466.7% | |
| Return on equity (ROE) |
10.0%
|
9.8%
|
10.4% |
| Change turnover |
0
|
-12 | |
| Change turnover % |
0%
|
-15% | |
| Chg. No. of employees |
0
|
0 | |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.